Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date द्वारा Bassiony S, Harrison CN, McLornan DP

पूर्ण पाठ प्राप्त करें

Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies द्वारा Mesa, RA, Hudgens, S, Floden, L, Harrison, CN, Palmer, J, Gupta, V, McLornan, DP, McMullin, MF, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, ML, Mead, AJ, Ross, DM, Oh, ST, Perkins, A, Leahy, MF, Deheshi, S, Donahue, R, Klencke, BJ, Verstovsek, S

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline द्वारा McLornan, DP, Godfrey, AL, Green, A, Frewin, R, Arami, S, Brady, J, Butt, NM, Cargo, C, Ewing, J, Francis, S, Garg, M, Harrison, C, Innes, A, Khan, A, Knapper, S, Lambert, J, Mead, A, McGregor, A, Neelakantan, P, Psaila, B, Somervaille, TCP, Woodley, C, Nangalia, J, Cross, NCP, McMullin, MF